Payam Nahid, MD, MPH

Associate Director, Clinical Trials Operations
Medicine
+1 628 206-5464

Dr. Nahid is Director of Clinical Trials Operations for UCSF in the Office of Research, and Professor in Residence in the Division of Pulmonary and Critical Care Medicine, Department of Medicine at Zuckerberg San Francisco General Hospital and UCSF. In his Office of Research capacity, Dr. Nahid is responsible for setting strategic priorities for clinical trial support at UCSF and directing the development of resources and services that the UCSF clinical trial community needs to be successful.  

Dr. Nahid is also a global health researcher and serves as the Director of the UCSF Center for Tuberculosis (TB), which aims to brings expertise across a range of disciplines to solve the problems that have historically undermined global TB elimination effort. He has led NIH- and CDC-funded field studies of TB diagnostics and clinical trials in TB therapeutics, including FDA-regulated studies. Dr. Nahid oversees NIH and Gates Foundation-sponsored TB biomarker discovery and qualification programs, serves as Chair of the Core Science Group for the Centers for Disease Control and Prevention’s TB Trials Consortium and has led and contributed to WHO Task Forces focused on TB clinical trial designs and development of new TB regimens. Dr. Nahid leads and has contributed to the development of U.S. and international practice guidelines for the treatment of TB.

Publications: 

Reply to Chang and Yew.

American journal of respiratory and critical care medicine

Sotgiu G, Battista Migliori G, Menzies D, Mase S, Chorba T, Seaworth B, Nahid P

Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.

Implementation science : IS

Kadota JL, Musinguzi A, Nabunje J, Welishe F, Ssemata JL, Bishop O, Berger CA, Patel D, Sammann A, Katahoire A, Nahid P, Belknap R, Phillips PPJ, Namusobya J, Kamya M, Handley MA, Kiwanuka N, Katamba A, Dowdy D, Semitala FC, Cattamanchi A

Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.

Annals of the American Thoracic Society

Berger CA, Alipanah N, Kheir F, Ruminjo JK, Nahid P, Thomson C

Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection.

Journal of clinical microbiology

Mehaffy C, Kruh-Garcia NA, Graham B, Jarlsberg LG, Willyerd CE, Borisov A, Sterling TR, Nahid P, Dobos KM

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis.

The Lancet. Respiratory medicine

Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D

Triumph and Tragedy of 21st Century Tuberculosis Drug Development.

The New England journal of medicine

Thwaites G, Nahid P

Advances in clinical trial design: Weaving tomorrow's TB treatments.

PLoS medicine

Lienhardt C, Nunn A, Chaisson R, Vernon AA, Zignol M, Nahid P, Delaporte E, Kasaeva T

High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

Contemporary clinical trials

Dorman SE, Nahid P, Kurbatova EV, Goldberg SV, Bozeman L, Burman WJ, Chang KC, Chen M, Cotton M, Dooley KE, Engle M, Feng PJ, Fletcher CV, Ha P, Heilig CM, Johnson JL, Lessem E, Metchock B, Miro JM, Nhung NV, Pettit AC, Phillips PPJ, Podany AT, Purfield AE, Robergeau K, Samaneka W, Scott NA, Sizemore E, Vernon A, Weiner M, Swindells S, Chaisson RE

Treatment of Drug-Susceptible Tuberculosis.

Clinics in chest medicine

Zha BS, Nahid P

Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California.

The Science of the total environment

Blount RJ, Pascopella L, Barry P, Zabner J, Stapleton EM, Flood J, Balmes J, Nahid P, Catanzaro DG

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

American journal of respiratory and critical care medicine

Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B

Multidrug-resistant tuberculosis - Authors' reply.

Lancet (London, England)

Menzies D, Benedetti A, Migliori GB, Nahid P, Seaworth B

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening.

Diagnostics (Basel, Switzerland)

Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.

PloS one

Broger T, Tsionksy M, Mathew A, Lowary TL, Pinter A, Plisova T, Bartlett D, Barbero S, Denkinger CM, Moreau E, Katsuragi K, Kawasaki M, Nahid P, Sigal GB

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.

PLoS medicine

Phillips PPJ, Mitnick CD, Neaton JD, Nahid P, Lienhardt C, Nunn AJ

Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

American journal of respiratory and critical care medicine

Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.

Nature medicine

Imperial MZ, Nahid P, Phillips PPJ, Davies GR, Fielding K, Hanna D, Hermann D, Wallis RS, Johnson JL, Lienhardt C, Savic RM

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.

Journal of clinical microbiology

Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.

Nature medicine

Imperial MZ, Nahid P, Phillips PPJ, Davies GR, Fielding K, Hanna D, Hermann D, Wallis RS, Johnson JL, Lienhardt C, Savic RM

The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.

The clinical respiratory journal

Korkmaz Ekren P, Töreyin ZN, Nahid P, Doskaya M, Caner A, Turgay N, Zeytinoglu A, Toz S, Bacakoglu F, Guruz Y, Erensoy S

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Lancet (London, England)

Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D

Tuberculosis.

Emergency Management of Infectious Diseases

Robert Blount, Payam Nahid, Adithya Cattamanchi

Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis.

Tuberculosis (Edinburgh, Scotland)

Kedia K, Wendler JP, Baker ES, Burnum-Johnson KE, Jarsberg LG, Stratton KG, Wright AT, Piehowski PD, Gritsenko MA, Lewinsohn DM, Sigal GB, Weiner MH, Smith RD, Jacobs JM, Nahid P

Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.

BMC infectious diseases

Walter ND, Moore CM, Kayigire XA, Dide-Agossou C, Worodria W, Huang L, Everett CK, Schoolnik GS, Nahid P, Davis JL

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis.

PloS one

Nahid P, Jarlsberg LG, Kato-Maeda M, Segal MR, Osmond DH, Gagneux S, Dobos K, Gold M, Hopewell PC, Lewinsohn DM

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial.

EBioMedicine

Sigal GB, Segal MR, Mathew A, Jarlsberg L, Wang M, Barbero S, Small N, Haynesworth K, Davis JL, Weiner M, Whitworth WC, Jacobs J, Schorey J, Lewinsohn DM, Nahid P

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

Environmental health perspectives

Blount RJ, Pascopella L, Catanzaro DG, Barry PM, English PB, Segal MR, Flood J, Meltzer D, Jones B, Balmes J, Nahid P

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Feng JY, Jarlsberg LG, Salcedo K, Rose J, Janes M, Lin SG, Osmond DH, Jost KC, Soehnlen MK, Flood J, Graviss EA, Desmond E, Moonan PK, Nahid P, Hopewell PC, Kato-Maeda M

Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Feng JY, Jarlsberg LG, Rose J, Grinsdale JA, Janes M, Higashi J, Osmond DH, Nahid P, Hopewell PC, Kato-Maeda M

Vitamin D Deficiency in Patients Referred for Evaluation of Obstructive Sleep Apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Salepci B, Caglayan B, Nahid P, Parmaksiz ET, Kiral N, Fidan A, Comert SS, Dogan C, Gungor GA

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

The Lancet. Respiratory medicine

Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

Clinical pharmacology and therapeutics

Savic RM, Weiner M, MacKenzie WR, Engle M, Whitworth WC, Johnson JL, Nsubuga P, Nahid P, Nguyen NV, Peloquin CA, Dooley KE, Dorman SE

First in vivo magnetic particle imaging of lung perfusion in rats.

Physics in medicine and biology

Zhou XY, Jeffris KE, Yu EY, Zheng B, Goodwill PW, Nahid P, Conolly SM

Target regimen profiles for treatment of tuberculosis: a WHO document.

The European respiratory journal

Lienhardt C, Nahid P, Rich ML, Bansbach C, Kendall EA, Churchyard G, González-Angulo L, D'Ambrosio L, Migliori GB, Raviglione M

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.

PLoS medicine

Kendall EA, Shrestha S, Cohen T, Nuermberger E, Dooley KE, Gonzalez-Angulo L, Churchyard GJ, Nahid P, Rich ML, Bansbach C, Forissier T, Lienhardt C, Dowdy DW

Tuberculosis Treatment.

International Encyclopedia of Public Health

Payam Nahid, Philip C. Hopewell

Treatment of Drug-Susceptible Tuberculosis.

Annals of the American Thoracic Society

Dela Cruz CS, Lyons PG, Pasnick S, Weinstock T, Nahid P, Wilson KC, Thomson CC

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P

Reply to Alffenaar et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Peloquin CA, Dorman SE, Vernon A, Battista Migliori G, Nahid P

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.

Journal of clinical microbiology

Jayakumar A, Savic RM, Everett CK, Benator D, Alland D, Heilig CM, Weiner M, Friedrich SO, Martinson NA, Kerrigan A, Zamudio C, Goldberg SV, Whitworth WC, Davis JL, Nahid P

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A

The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis.

The European respiratory journal

Sotgiu G, Nahid P, Loddenkemper R, Abubakar I, Miravitlles M, Migliori GB

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

BMC public health

Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P

Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients.

The Journal of infectious diseases

Walter ND, de Jong BC, Garcia BJ, Dolganov GM, Worodria W, Byanyima P, Musisi E, Huang L, Chan ED, Van TT, Antonio M, Ayorinde A, Kato-Maeda M, Nahid P, Leung AM, Yen A, Fingerlin TE, Kechris K, Strong M, Voskuil MI, Davis JL, Schoolnik GK

Urban tree coverage associated with reduced mortality among tuberculosis (TB) patients undergoing treatment in California.

ISEE Conference Abstracts

Robert J Blount*, Lisa Pascopella, Pennan Barry, Dan Meltzer, Jenny Flood, Paul B English, Mark R Segal, Payam Nahid, John Balmes, Donald G Catanzaro

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).

BMC medicine

Phillips PP, Dooley KE, Gillespie SH, Heinrich N, Stout JE, Nahid P, Diacon AH, Aarnoutse RE, Kibiki GS, Boeree MJ, Hoelscher M

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P

Challenges in the clinical assessment of novel tuberculosis drugs.

Advanced drug delivery reviews

Dooley KE, Phillips PP, Nahid P, Hoelscher M

A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nicol MP, Gnanashanmugam D, Browning R, Click ES, Cuevas LE, Detjen A, Graham SM, Levin M, Makhene M, Nahid P, Perez-Velez CM, Reither K, Song R, Spiegel HM, Worrell C, Zar HJ, Walzl G

Evaluation of mobile digital light-emitting diode fluorescence microscopy in Hanoi, Viet Nam.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Chaisson LH, Reber C, Phan H, Switz N, Nilsson LM, Myers F, Nhung NV, Luu L, Pham T, Vu C, Nguyen H, Nguyen A, Dinh T, Nahid P, Fletcher DA, Cattamanchi A

In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

Diagnostic microbiology and infectious disease

Slater M, Tran MC, Platt L, Luu LT, Phan HT, Pham PT, Do TB, Nguyen HT, Gaur RL, Parsonnet J, Cattamanchi A, Luo R, Nahid P, Banaei N

Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Tuberculosis (Edinburgh, Scotland)

Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, Yoon C, Kato-Maeda M, Nahid P

Towards tuberculosis elimination: an action framework for low-incidence countries.

The European respiratory journal

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunovic A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC

Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

The Journal of infectious diseases

Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de Jong BC, Davidson RM, Fingerlin TE, Kechris K, Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi A, Strong M, Schoolnik GK, Davis JL

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

American journal of respiratory and critical care medicine

Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger N, Muzanyi G, Johnson JL, Nahid P, Hecker EJ, Heilig CM, Bozeman L, Feng PJ, Moro RN, MacKenzie W, Dooley KE, Nuermberger EL, Vernon A, Weiner M

Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS.

PloS one

Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM

Non-tuberculous mycobacterial infections at San Francisco General Hospital.

The clinical respiratory journal

Sheu LC, Tran TM, Jarlsberg LG, Marras TK, Daley CL, Nahid P

Childhood tuberculosis in northern Viet Nam: a review of 103 cases.

PloS one

Blount RJ, Tran B, Jarlsberg LG, Phan H, Thanh Hoang V, Nguyen NV, Lewinsohn DA, Nahid P

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.

PloS one

Budzik JM, Jarlsberg LG, Higashi J, Grinsdale J, Hopewell PC, Kato-Maeda M, Nahid P

Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.

Journal of acquired immune deficiency syndromes (1999)

Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, Bangsberg DR, Nahid P, Semitala FC, Hunt PW, Martin JN, Cattamanchi A

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Tuberculosis (Edinburgh, Scotland)

Nahid P, Bliven-Sizemore E, Jarlsberg LG, De Groote MA, Johnson JL, Muzanyi G, Engle M, Weiner M, Janjic N, Sterling DG, Ochsner UA

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection.

Journal of the Pediatric Infectious Diseases Society

Chang SH, Nahid P, Eitzman SR

Update in tuberculosis and nontuberculous mycobacterial disease 2012.

American journal of respiratory and critical care medicine

Menzies D, Nahid P

Advances in the development of new tuberculosis drugs and treatment regimens.

Nature reviews. Drug discovery

Zumla A, Nahid P, Cole ST

Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.

PloS one

De Groote MA, Nahid P, Jarlsberg L, Johnson JL, Weiner M, Muzanyi G, Janjic N, Sterling DG, Ochsner UA

Drug-resistant tuberculosis: time for visionary political leadership.

The Lancet. Infectious diseases

Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.

The Journal of infectious diseases

Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW

Update in tuberculosis and nontuberculous mycobacterial disease 2011.

American journal of respiratory and critical care medicine

Nahid P, Menzies D

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.

PloS one

Dantes R, Metcalfe J, Kim E, Kato-Maeda M, Hopewell PC, Kawamura M, Nahid P, Cattamanchi A

Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

The Journal of infectious diseases

Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S

Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.

Tuberculosis (Edinburgh, Scotland)

Goodridge A, Cueva C, Lahiff M, Muzanye G, Johnson JL, Nahid P, Riley LW

Mycobacterium tuberculosis lineage--what's in your lungs?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Kato-Maeda M, Nahid P

Major Radiation Exposure.

Denis D. Bensard, Philip F. Stahel, Jorge Cerdá, Babak Sarani, Sajid Shahul, Daniel Talmor, Peter M. Hammer, C. William Schwab, Steven Reynolds, Omar Ahmad, Tsuyoshi Kaneko, Anthony L. Estrera, William A. Knight, Bradley P. Dixon, Richard L. Gamelli, Joseph A. Posluszny, Mansoor N. Bangash, Rupert M. Pearse, Albert J. Ruggieri, Richard J. Levy, Clifford S. Deutschman, Clifford S. Deutschman, Richard J. Levy, Prasanna Simha Mohan Rao, John P. Kress, Sabino Scolletta, Norman E. McSwain, Jeffry L. Kashuk, Angela Sauaia, Ernest E. Moore, Per-Olof J. Hasselgren, Wade R. Smith, John T. Riehl, Denis D. Bensard, Philip F. Stahel, Berton R. Moed, B. Kirke Bieneman, Berton R. Moed, Clay C. Cothren, Ernest E. Moore, Nima Majlesi, Richard D. Shih, Eelco F. M. Wijdicks, Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn, Julie P. Chou, Tom Lim, Andrew G. Lee, Christopher H. Mody, Tom Lim, Julie P. Chou, Christopher H. Mody, Nathan T. Mowery, Alexander L. Colonna, J. Wayne Meredith, Alain Combes, Jonathan R. Egan, Marino S. Festa, A. Montcriol, Y. Asencio, F. Kerbaul

Mycobacterial Infections in the non-HIV–Infected Patient.

Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

American journal of respiratory and critical care medicine

Nahid P, Saukkonen J, Mac Kenzie WR, Johnson JL, Phillips PP, Andersen J, Bliven-Sizemore E, Belisle JT, Boom WH, Luetkemeyer A, Campbell TB, Eisenach KD, Hafner R, Lennox JL, Makhene M, Swindells S, Villarino ME, Weiner M, Benson C, Burman W

Racial differences in tuberculosis infection in United States communities: the coronary artery risk development in young adults study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Nahid P, Horne DJ, Jarlsberg LG, Reiner AP, Osmond D, Hopewell PC, Bibbins-Domingo K

Discriminating between latent and active tuberculosis with multiple biomarker responses.

Tuberculosis (Edinburgh, Scotland)

Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E, Nahid P, Ferrari G, Stout JE

Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Steingart KR, Jotblad S, Robsky K, Deck D, Hopewell PC, Huang D, Nahid P

Sputum monitoring during tuberculosis treatment for predicting outcome Authors' reply.

The Lancet Infectious Diseases

David J Horne, Sarah E Royce, Masahiro Narita, Payam Nahid, Karen R Steingart

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

BMC infectious diseases

Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

The Lancet. Infectious diseases

Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, Steingart KR

Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.

PloS one

Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M

Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis.

Journal of clinical microbiology

Kim EY, Nahid P, Hopewell PC, Kato-Maeda M

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects.

American journal of respiratory and critical care medicine

Metcalfe JZ, Cattamanchi A, Vittinghoff E, Ho C, Grinsdale J, Hopewell PC, Kawamura LM, Nahid P

Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis.

Emerging infectious diseases

Burman WJ, Bliven EE, Cowan L, Bozeman L, Nahid P, Diem L, Vernon A

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, Osmond D, Hopewell PC, Nahid P

Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.

Clinical and vaccine immunology : CVI

Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell PC, Ramsay A, Pai M, Laal S

Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.

Chest

Cattamanchi A, Nahid P, Marras TK, Gotway MB, Lee TJ, Gonzalez LC, Morris A, Webb WR, Osmond DH, Daley CL

Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples.

Nursing research

Nyamathi A, Nahid P, Berg J, Burrage J, Christiani A, Aqtash S, Morisky D, Leake B

On Treatment Outcomes of Patients with HIV and Tuberculosis.

American journal of respiratory and critical care medicine

Payam Nahid, Bouke C. de Jong, Charles L. Daley

Reaching the limits of tuberculosis prevention among foreign-born individuals: a tuberculosis-control program perspective.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Walter ND, Jasmer RM, Grinsdale J, Kawamura LM, Hopewell PC, Nahid P

Tuberculosis Treatment.

International Encyclopedia of Public Health

P. Nahid, P.C. Hopewell

Tuberculosis.

Emergency Management of Infectious Diseases

Adithya Cattamanchi, Payam Nahid

Treatment outcomes of patients with HIV and tuberculosis.

American journal of respiratory and critical care medicine

Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL

Unusual finding on bronchoscopy: trauma patient identified as a body stuffer.

Journal of clinical anesthesia

Chang C, Grush A, McClintock DE, Nahid P, Tang JF

A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Nyamathi AM, Christiani A, Nahid P, Gregerson P, Leake B

Prevention of tuberculosis in HIV-infected patients.

Current opinion in infectious diseases

Nahid P, Daley CL

Advances in the diagnosis and treatment of tuberculosis.

Proceedings of the American Thoracic Society

Nahid P, Pai M, Hopewell PC

Clinical practice. Latent tuberculosis infection.

The New England journal of medicine

Jasmer RM, Nahid P, Hopewell PC